Amarin Corporation plc (NASDAQ: AMRN) is having a strong start to the trading session this morning, and for good reason. The company announced that the… Read More »Amarin Corporation (AMRN) Stock Heads Up On FDA Approval
Amarin Corporation plc (NASDAQ: AMRN) is having a great start to the trading session this morning, and for good reason. As I’ve been pointing to… Read More »Amarin (AMRN) Stock Heads Up On Advisory Committee Recommendation
Amarin Corporation plc (NASDAQ: AMRN) is making a run for the top in the market this morning, up more than 16% in the premarket. While… Read More »Amarin Corporation (AMRN) Stock Gains On Vascepa Excitement
Amarin Corporation plc (NASDAQ: AMRN) is trading in the green this morning after releasing its results for the third quarter. The company reported record prescriptions… Read More »Amarin Corporation (AMRN) Stock: Are You In Yet?
Amarin Corporation plc (NASDAQ: AMRN) is tumbling in the market this morning after announcing a surprise advisory committee review for Vascepa. While the surprise means… Read More »Amarin (AMRN) Stock Declines Are A Welcomed Discount
Amarin Corporation plc (NASDAQ: AMRN) is having an incredibly strong start to the trading session Tuesday morning after the company announced a corporate update. In… Read More »Amarin Corporation (AMRN) Stock Climbs On Corporate Update
Amarin Corporation plc (NASDAQ: AMRN) is a stock that I’ve been watching closely as of late. With the stock down more than 3% today, many… Read More »Amarin (AMRN) Stock Is Dipping: Grab The Discount!
I’ve been following Amarin Corporation plc (NASDAQ: AMRN) for some time now, and if you’ve read my detailed post (available here), you know that I… Read More »Amarin (AMRN) Stock: A Blockbuster In The Making
Amarin Corporation plc (NASDAQ: AMRN) is seeing quite a bit of after-hours chatter this evening. According to various posts on message boards and social media,… Read More »Amarin Corporation (AMRN) Stock: Worth Considering Regardless Of Rumors